MIMEDX Group, Inc.

Home
United States
Atlanta, GA
MIMEDX Group, Inc.

Patients are why we are here. MIMEDX has supplied over two million allografts, through both direct and consignment shipments.

MIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. For additional information, please visit www.mimedx.com.

12/10/2025

The future of surgical care is here — and we’re inviting distributors to be part of it.
MIMEDX continues to expand its footprint in advanced surgical tissue products and is seeking 1099 surgical agents with strong OR-based relationships to grow their portfolios with a trusted leader in innovation, integrity, and outcomes.

MIMEDX offers placental-based and xenograft surgical products supported by strong nationwide GPO and IDN contracts and partnerships, providing exceptional access to the OR.

Preferred experience includes Spine, Ortho, Neuro, Colorectal, GYN, and Foot & Ankle specialties, among others.

Partner with a trusted name in surgical innovation and patient care.
Contact Frank Braly at fbraly@mimedx.com, Bill Timony at btimony@mimedx.com, or contact us here: https://mimedx.info/Contact-Us

12/09/2025

Did you know that MIMEDX has the most Level I RCTs of any placental allograft company? With seven RCTs demonstrating the safety and efficacy of EPIFIX® and EPICORD®, we are empowering clinicians with evidence to enhance patient outcomes.

Learn more about the science behind our advanced wound and surgical solutions: https://bit.ly/3v2A52R

12/03/2025

Did you know? MIMEDX partner, WoundGenex, offers the Premier Graft Program to make advanced wound care more accessible by offering practices support with documentation, reimbursement, and payment timing.

🔗Learn more in our overview video featuring our WoundGenex partners: https://mimedx.info/WoundGenex-PGP-Overview-Video

12/02/2025

MIMEDX leads the way with seven Level I RCTs validating the safety and efficacy of EPIFIX® and EPICORD® allografts. Clinicians can trust in our evidence-based solutions to enhance patient care.

Get started with MIMEDX® advanced wound solutions today: https://bit.ly/41mNpLw

11/26/2025

Do you have a loved one dealing with a hard-to-heal wound? It's important to recognize the social impact chronic wounds can have on patients and to understand the various treatment options.

Learn how MIMEDX can help: https://bit.ly/patients-caregivers

11/25/2025

AMNIOFIX® is an advanced human amnion/chorion placental allograft that provides a protective barrier to support the healing cascade. It is available in sheet and fenestrated sheet configurations in a variety of sizes for surgical wounds.

Learn how AMNIOFIX can benefit your surgical practice at https://bit.ly/3vY9og9

11/20/2025

Did you know? EPIFIX® is the #1 most studied human placental allograft. Trusted by healthcare providers for its proven clinical success and cost-effectiveness, EPIFIX delivers positive clinical outcomes for patients with:

✅Diabetic foot ulcers
✅Venous leg ulcers
✅and other chronic wounds

Take the lead in advanced wound care. Choose EPIFIX: https://bit.ly/3RCh28j

11/19/2025

MIMEDX is seeking 1099 surgical agents with strong OR-based relationships to expand their bag with placental and xenograft surgical products. MIMEDX maintains strong nationwide GPO and IDN contracts and partnerships, providing excellent access to the OR.

Preferred experience includes Spine, Ortho, Neuro, Colorectal, GYN, and Foot & Ankle specialties, among others.

If you have experience selling surgical products and are passionate about supporting patient care, let’s connect. Contact Frank Braly at fbraly@mimedx.com, Bill Timony at btimony@mimedx.com, or contact us here: https://mimedx.info/Contact-Us

11/18/2025

Hear expert insights from Gary S. Rodgers, MD, an author of the recently published “Placental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis.”

Watch now: https://mimedx.info/Mohs-Hecon-Spotlight

11/13/2025

Big thanks to Dr. Das for an outstanding keynote presentation at the Chicago Society of Colon and Re**al Surgeons fall meeting!

Over 50 colorectal surgeons packed the room to hear Dr. Das share compelling evidence supporting the use of dehydrated human amnion/chorion membrane (DHACM) allografts in colectomies and other colorectal procedures. The session sparked a robust and engaging discussion.

🔍Interested in how AMNIOFIX may be used as a protective barrier to support the healing cascade in colorectal surgery? 👉Learn more at: https://mimedx.info/general-surgery

11/12/2025

MIMEDX offers distributors a proven portfolio of leading surgical tissue products backed by science, clinical evidence, and lasting partnerships.

We’re seeking 1099 surgical agents with strong OR-based relationships to expand their bag with placental and xenograft surgical products. MIMEDX has strong nationwide GPO and IDN contracts and partnerships, providing excellent access to the OR.

Preferred relationships and experience include Spine, Ortho, Neuro, Colorectal, GYN, and Foot & Ankle specialties, among others.

Together, we can expand access to innovative products that help surgeons advance patient care.

💼Contact Frank Braly at fbraly@mimedx.com, Bill Timony at btimony@mimedx.com, or learn more: https://mimedx.info/Contact-Us

11/10/2025

👣 Upcoming Webinar: Advancing Diabetic Care in Rural Hospitals

Rural and Critical Access Hospitals play a vital role in preventing diabetic amputations — and education can make all the difference.
Join the National Rural Health Association (NRHA) and MIMEDX for a free live webinar led by Anthony Iorio, DPM, FACFAS, FAPWHc, exploring evidence-based strategies to reduce amputations, improve patient outcomes, and preserve lives.

📅Wednesday, November 19, 2025
🕑2:00–3:00 PM ET | 11:00–12:00 PM PT
💻Register here: https://mimedx.info/NRHA-Webinar

Address

Atlanta, GA

Telephone

+17706519100

Website

http://www.mimedx.com/

Alerts

Be the first to know and let us send you an email when MIMEDX Group, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Atlanta?